Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world-leader in NGS services, with thousands of employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 37 NGS-related patents, as well as over 670 research papers with total impact factor at more than 4930, including publications in first tiers journals such as Cell, Nature and Science. As the largest NGS service provider headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands, Japan and Thailand, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has global genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).